Patients with metastatic papillary renal cell carcinoma (RCC) who may benefit from sunitinib therapy (tx): Results from an international metastatic RCC database. Prevalence of grade 3 or greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results